Nicole A Short1, Michael J Zvolensky2, Norman B Schmidt3. 1. Department of Psychology, Florida State University, Tallahassee, FL, USA; Department of Anesthesiology, University of North Carolina, Chapel Hill, NC, USA. 2. Department of Psychology, University of Houston, Houston, TX, USA; MD Anderson Cancer Center, Houston, TX, USA. 3. Department of Psychology, Florida State University, Tallahassee, FL, USA. Electronic address: schmidt@psy.fsu.edu.
Abstract
BACKGROUND: Insomnia symptoms may be an important etiological factor for substance use disorders; however, whether improving sleep leads to reductions in problematic substance use among at-risk populations remains unclear. METHOD: As such, the current pilot study used a randomized controlled design to test the effects of Brief Behavioral Treatment for Insomnia (BBTI) against a waitlist control among a sample of trauma-exposed young adults with elevated insomnia symptoms who regularly use cannabis (N = 56). RESULTS: Intent-to-treat multilevel modeling analyses indicated that BBTI may be more efficacious than waitlist control in reducing self-reported insomnia symptoms, with large effects three months post-treatment (d = 1.34). Further, our initial evidence suggested that BBTI resulted in reductions in cannabis-related problems with medium to large effects at three months post-treatment (d = 0.75). The current pilot analyses indicated BBTI also reduced cravings to use cannabis to reduce negative emotions in response to trauma cues with a large effect size. CONCLUSION: This pilot study suggests BBTI may be efficacious not only in improving insomnia symptoms among cannabis users but also in reducing cannabis-related problems and cravings over three months. Future research should replicate these results in a larger, fully powered sample with improved follow-up rates designed to test temporal mediation using multimethod assessments of insomnia symptoms and problematic cannabis use. Overall, BBTI may be a promising intervention for trauma-exposed cannabis users to improve sleep and reduce cannabis-related problems.
BACKGROUND: Insomnia symptoms may be an important etiological factor for substance use disorders; however, whether improving sleep leads to reductions in problematic substance use among at-risk populations remains unclear. METHOD: As such, the current pilot study used a randomized controlled design to test the effects of Brief Behavioral Treatment for Insomnia (BBTI) against a waitlist control among a sample of trauma-exposed young adults with elevated insomnia symptoms who regularly use cannabis (N = 56). RESULTS: Intent-to-treat multilevel modeling analyses indicated that BBTI may be more efficacious than waitlist control in reducing self-reported insomnia symptoms, with large effects three months post-treatment (d = 1.34). Further, our initial evidence suggested that BBTI resulted in reductions in cannabis-related problems with medium to large effects at three months post-treatment (d = 0.75). The current pilot analyses indicated BBTI also reduced cravings to use cannabis to reduce negative emotions in response to trauma cues with a large effect size. CONCLUSION: This pilot study suggests BBTI may be efficacious not only in improving insomnia symptoms among cannabis users but also in reducing cannabis-related problems and cravings over three months. Future research should replicate these results in a larger, fully powered sample with improved follow-up rates designed to test temporal mediation using multimethod assessments of insomnia symptoms and problematic cannabis use. Overall, BBTI may be a promising intervention for trauma-exposed cannabis users to improve sleep and reduce cannabis-related problems.
Authors: L E de Graaf; S A H Gerhards; A Arntz; H Riper; J F M Metsemakers; S M A A Evers; J L Severens; G Widdershoven; M J H Huibers Journal: Br J Psychiatry Date: 2009-07 Impact factor: 9.319
Authors: Daniel J Buysse; Anne Germain; Douglas E Moul; Peter L Franzen; Laurie K Brar; Mary E Fletcher; Amy Begley; Patricia R Houck; Sati Mazumdar; Charles F Reynolds; Timothy H Monk Journal: Arch Intern Med Date: 2011-01-24
Authors: Kevin M Swift; Connie L Thomas; Thomas J Balkin; Emily G Lowery-Gionta; Liana M Matson Journal: J Clin Sleep Med Date: 2022-09-01 Impact factor: 4.324
Authors: Sean N Noudali; Julie A Patock-Peckham; Sophia L Berberian; Daniel A Belton; Lyndsay E Campbell; Frank J Infurna Journal: Addict Behav Rep Date: 2021-12-21